Deutsche Bank Maintains Hold on GoodRx Holdings, Raises Price Target to $8
Portfolio Pulse from Benzinga Newsdesk
Deutsche Bank analyst George Hill has maintained a 'Hold' rating on GoodRx Holdings (NASDAQ:GDRX) and raised the price target from $6 to $8.
August 10, 2023 | 8:02 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Deutsche Bank has maintained a 'Hold' rating on GoodRx Holdings and raised the price target from $6 to $8.
The news is directly related to GoodRx Holdings. The 'Hold' rating suggests that Deutsche Bank believes the stock will perform in line with the market, while the raised price target indicates an expectation of potential upside. However, as the rating is not an upgrade, the impact on the stock price may be neutral in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100